• Full Prescribing Information
  • Medication Guide
  • Before You Prescribe
  • Visit Patient Site
OxyContin® (OXYCODONE HCl EXTENDED-RELEASE TABLETS)
Key Attributes
Patient Assessment
  • Appropriate Use
  • Use in Specific Populations
Abuse-Deterrence Studies
  • Summary
  • OxyContin In Vitro Testing
  • OxyContin Abuse Potential Studies
  • Addiction, Abuse, Misuse, and Diversion/REMS
Dosing
  • Considerations for Prescribing
  • Initiation
  • Converting From IR Oxycodone
  • Converting From Other Opioids
  • Dosing Considerations
  • Reassess Continually
  • 7 Tablet Strengths
  • Titration
  • Safe Reduction or Discontinuation
Savings
Resources
  • Overview
  • REMS
  • Medication Guide
  • Before You Prescribe
  • Visit Patient Site
  • PurduePharma.com
  • Report an Adverse Event
  • Product Quality Complaint
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Site Map
Indication & Important
Safety Information
Full Prescribing
Information

Site map

  • Home
  • Before You Prescribe
  • Key Attributes
  • Patient Assessment
    • Appropriate Use
    • Use in Specific Populations
  • Abuse-Deterrence Studies (ADP)
    • Summary
    • OxyContin In Vitro Testing
    • OxyContin Abuse Potential Studies
    • Addiction, Abuse, Misuse, and Diversion/REMS
  • Dosing
    • Considerations for Prescribing
    • Initiation
    • Converting From IR Oxycodone
    • Converting From Other Opioids
    • Dosing Considerations
    • Reassess Continually
    • 7 Tablet Strengths
    • Titration
    • Safe Reduction or Discontinuation
  • Resources
    • Overview
    • REMS
Down arrow
  • Purdue Pharma Home
  • Full Prescribing Information
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Site Map
  • Abuse-Deterrence Labeling
  • Opioid Analgesics REMS
  • Do Not Sell My Information

©2023 Purdue Pharma L.P., Stamford, CT 06901-3431.

Intended for residents of the United States only.

Purdue, as used in this site, refers to Purdue Pharma L.P., a company in a network of independent associated companies.

MR-08207 12/2022

When you access any of our websites, related other parities’ websites, mobile applications, or any electronic service, we may use cookies and other technologies to automatically collect information regarding you and your device to assess user activity and preferences. We may also use third-party analytic tools to assist with the collection of information including, but not limited to, Google Analytics. By using this site, you agree to our use of these technologies in accordance with our Privacy Policy.